伊曲康唑联合莫沙比利与制霉菌素治疗霉菌性食管炎的疗效比较

    The clinical efficacy of itraconazole combined with mosapride and nystatin in the treatment of fungal esophagitis

    • 摘要: 目的:比较伊曲康唑联合莫沙必利与制霉菌素治疗霉菌性食管炎的临床疗效。方法:选取霉菌性食管炎患者188例,按照入院顺序随机分为2组,每组94例。对照组口服制霉菌素,观察组给予伊曲康唑联合莫沙必利,观察2组患者的临床疗效及不良反应。结果:观察组总有效率100.00%明显高于对照组的93.62%(P0.05);观察组无一例不良反应,对照组2例,2组不良反应发生率差异无统计学意义(P=0.497)。结论:伊曲康唑联合莫沙必利治疗霉菌性食管炎疗效显著,能有效缓解患者的临床症状,消除霉菌斑,是治疗霉菌性食管炎较理想的用药。

       

      Abstract: Objective: To compared the clinical efficacy of itraconazole combined with mosapride and nystatin in the treatment of fungal esophagitis. Methods: One hundred and eighty-eight patients with fungal esophagitis were randomly divided into the control group and observation group( 94 cases each group). The control group and observation group were treated with nystatin by oral and itraconazole combined with mosapride,respectively. The clinical efficacy and adverse reactions in two groups were compared. Results: The total effective rate in observation group( 100. 00%) were higher than those in control group( 93. 62%)( P 0. 05). Two cases with adverse reaction in control group and no adverse reaction in observation group were found,the difference of the occurrence rate of adverse reaction in two groups was not statically significant( P = 0. 497). Conclusions: The effects of itraconazole combined with mosapride in the treatment of fungal esophagitis are notable,which can effectively relieve clinical symptoms and eliminate mold spots,it is a ideal medication for fungal esophagitis.

       

    /

    返回文章
    返回